TYPE 2 DIABETES MELLITUS AND HEPATOCELLULAR CARCINOMA ARE RISK FACTORS FOR HEPATIC ENCEPHALOPATHY IN PATIENTS WITH END-STAGE LIVER DISEASE

被引：0
|
作者：
Sundaram, Vinay [1 ]
Ganesh, Swaytha [2 ]
Behari, Jaideep [1 ]
机构：
[1] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1216
引用
收藏
页码：911A / 912A
页数：2
相关论文
共 50 条
  • [1] Risk Factors Associated with End-Stage Renal Disease in Type 2 Diabetes Mellitus Patients
    Putri, Suci Tuty
    4TH INTERNATIONAL VIRTUAL CONFERENCE ON NURSING, 2021, : 907 - 919
  • [2] Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease
    Stewart, Charmaine A.
    Malinchoc, Michael
    Kim, W. Ray
    Kamath, Patrick S.
    LIVER TRANSPLANTATION, 2007, 13 (10) : 1366 - 1371
  • [3] Hepatic Encephalopathy in End-Stage Liver Disease #188
    Childers, Julie Wilson
    Arnold, Robert M.
    JOURNAL OF PALLIATIVE MEDICINE, 2008, 11 (10) : 1341 - 1342
  • [4] A Risk Prediction Model for End-Stage Renal Disease in Patients with Type 2 Diabetes Mellitus
    Geba, Daniela
    Cordova, Jeanine M.
    Shetty, Sharash
    Williams, Brent
    DIABETES, 2019, 68
  • [5] Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
    Qi, Yueying
    Fan, Lirong
    Ran, Decong
    Xu, Jieda
    Wang, Yuansong
    Wu, Jin
    Zhang, Zhongyong
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [6] INTERLEUKIN-6, GENDER AND RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH END-STAGE LIVER DISEASE
    Fumolo, E.
    Fornasiere, E.
    Bitetto, D.
    Fontanini, E.
    Cussigh, A.
    Bragagnini, W.
    Falleti, E.
    Fabris, C.
    Minisini, R.
    Toniutto, P.
    Pirisi, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S289 - S290
  • [7] A Simplified Multivisceral Transplantation Procedure for Patients With Combined End-Stage Liver Disease and Type 2 Diabetes Mellitus
    He, Xiao-Shun
    Fu, Shun-Jun
    Zhao, Qiang
    Zhu, Xiao-Feng
    Wang, Dong-Ping
    Han, Ming
    Ju, Wei-Qiang
    Ma, Yi
    Jiao, Xing-Yuan
    Yuan, Xiao-Peng
    Hu, An-Bin
    Guo-, Zhi-Yong
    LIVER TRANSPLANTATION, 2017, 23 (09) : 1161 - 1170
  • [8] A Simplified Multivisceral Transplantation Procedure for Patients with Combined End-stage Liver Disease and Type 2 Diabetes Mellitus
    He, X-S
    Fu, S-J
    Zhao, Q.
    Zhu, X-F
    Wang, D-P
    Han, M.
    Ju, W-Q
    Ma, Y.
    Jiao, X-Y
    Yuan, X-P
    Hu, A-B
    Guo, Z-Y
    TRANSPLANTATION, 2017, 101 (05) : 40 - 40
  • [9] Risk factors for osteoporosis in patients with end-stage liver disease
    Uchida, Shinjiro
    Miyaaki, Hisamitsu
    Ichikawa, Tatsuki
    Taura, Naota
    Miuma, Satoshi
    Honda, Takuya
    Shibata, Hidetaka
    Haraguchi, Masafumi
    Senoo, Takemasa
    Nakao, Kazuhiko
    BIOMEDICAL REPORTS, 2016, 5 (05) : 629 - 633
  • [10] Model for end-stage liver disease (MELD) exception for hepatic encephalopathy
    Ham, John
    Gish, Robert G.
    Mullen, Kevin
    LIVER TRANSPLANTATION, 2006, 12 (12) : S102 - S104
12345